Necrosis inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 10555920
APP PUB NO 20190038578A1
SERIAL NO

16153706

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides amides that inhibit cellular necrosis and/or human receptor interacting protein 1 kinase (RIP1), including corresponding sulfonamides, and pharmaceutically acceptable salts, hydrates and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES BEIJINGBEIJING 102206

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ren, Yan Beijing, CN 108 196
Ruan, Hanying Beijing, CN 7 2
Su, Yaning Beijing, CN 13 3
Wang, Xiaodong Beijing, CN 544 6681
Zhang, Zhiyuan Beijing, CN 150 2053

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 11, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 11, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00